Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For DSGX
Valuation Bad
0%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Balanced
50%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -27.25 1.49 2.05
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 22.92 -3.61 -4.68
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.47 14.81 14.45
Cash -25.44 2.79 3.75
Capex -138.97 -0.02 < 0.005
Free Cash Flow 20.86 0.72 0.59
Revenue -0.15 1.75 1.75
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 1.86 0.67 0.65
Operating Margin -4.49 0.32 0.34
ROA 3.69 0.02 0.02
ROE 6.09 0.03 0.03
ROIC -12.02 0.03 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of DSGX is permitted for members.
5 Growth
The "Growth Entry" for the Focus of DSGX is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of DSGX is permitted for members.